| Clinical and economic burden of adverse drug reactions J Sultana, P Cutroneo, G Trifirò Journal of Pharmacology and Pharmacotherapeutics 4 (1_suppl), S73-S77, 2013 | 611 | 2013 |
| Sample Size Considerations for Pharmacoepidemiologic Studies BL Strom Textbook of Pharmacoepidemiology, 30-39, 2013 | 329* | 2013 |
| Global epidemiology of Duchenne muscular dystrophy: an updated systematic review and meta-analysis S Crisafulli, J Sultana, A Fontana, F Salvo, S Messina, G Trifirò Orphanet journal of rare diseases 15, 1-20, 2020 | 304 | 2020 |
| The economic burden of preventable adverse drug reactions: a systematic review of observational studies D Formica, J Sultana, PM Cutroneo, S Lucchesi, R Angelica, S Crisafulli, ... Expert opinion on drug safety 17 (7), 681-695, 2018 | 195 | 2018 |
| Azithromycin in COVID-19 patients: pharmacological mechanism, clinical evidence and prescribing guidelines J Sultana, PM Cutroneo, S Crisafulli, G Puglisi, G Caramori, G Trifirò Drug safety 43, 691-698, 2020 | 187 | 2020 |
| Challenges for drug repurposing in the COVID-19 pandemic era J Sultana, S Crisafulli, F Gabbay, E Lynn, S Shakir, G Trifirò Frontiers in pharmacology 11, 588654, 2020 | 149 | 2020 |
| Drug repositioning and repurposing for Alzheimer disease C Ballard, D Aarsland, J Cummings, J O’Brien, R Mills, JL Molinuevo, ... Nature Reviews Neurology 16 (12), 661-673, 2020 | 136 | 2020 |
| Association of individual non-steroidal anti-inflammatory drugs and chronic kidney disease: a population-based case control study Y Ingrasciotta, J Sultana, F Giorgianni, A Fontana, A Santangelo, DU Tari, ... PLoS One 10 (4), e0122899, 2015 | 121 | 2015 |
| Potential effects of vaccinations on the prevention of COVID-19: rationale, clinical evidence, risks, and public health considerations J Sultana, G Mazzaglia, N Luxi, A Cancellieri, A Capuano, C Ferrajolo, ... Expert review of vaccines 19 (10), 919-936, 2020 | 116 | 2020 |
| Antidepressant use in the elderly: the role of pharmacodynamics and pharmacokinetics in drug safety J Sultana, E Spina, G Trifirò Expert opinion on drug metabolism & toxicology 11 (6), 883-892, 2015 | 105 | 2015 |
| The burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern Italy Y Ingrasciotta, J Sultana, F Giorgianni, AP Caputi, V Arcoraci, DU Tari, ... PloS one 9 (2), e89072, 2014 | 85 | 2014 |
| The role of European healthcare databases for post-marketing drug effectiveness, safety and value evaluation: where does Italy stand? G Trifirò, R Gini, F Barone-Adesi, E Beghi, A Cantarutti, A Capuano, ... Drug Safety 42, 347-363, 2019 | 83 | 2019 |
| From big data to smart data for pharmacovigilance: the role of healthcare databases and other emerging sources G Trifirò, J Sultana, A Bate Drug safety 41, 143-149, 2018 | 82 | 2018 |
| Survival of hospitalized COVID-19 patients in Northern Italy: a population-based cohort study by the ITA-COVID-19 Network E Ferroni, P Giorgi Rossi, S Spila Alegiani, G Trifirò, G Pitter, O Leoni, ... Clinical Epidemiology, 1337-1346, 2020 | 68 | 2020 |
| Use of azithromycin and risk of ventricular arrhythmia G Trifirò, M De Ridder, J Sultana, A Oteri, P Rijnbeek, S Pecchioli, ... Cmaj 189 (15), E560-E568, 2017 | 61 | 2017 |
| Global epidemiology of acromegaly: a systematic review and meta-analysis S Crisafulli, N Luxi, J Sultana, A Fontana, F Spagnolo, G Giuffrida, ... European journal of endocrinology 185 (2), 251-263, 2021 | 60 | 2021 |
| Renin–angiotensin–aldosterone system inhibitors and risk of death in patients hospitalised with COVID-19: a retrospective Italian cohort study of 43,000 patients G Trifirò, M Massari, R Da Cas, F Menniti Ippolito, J Sultana, S Crisafulli, ... Drug Safety 43, 1297-1308, 2020 | 57 | 2020 |
| Indications of newer and older anti‐epileptic drug use: findings from a southern Italian general practice setting from 2005–2011 D Italiano, A Capuano, A Alibrandi, R Ferrara, A Cannata, G Trifirò, ... British journal of clinical pharmacology 79 (6), 1010-1019, 2015 | 52 | 2015 |
| Are the safety profiles of antipsychotic drugs used in dementia the same? An updated review of observational studies G Trifiró, J Sultana, E Spina Drug safety 37, 501-520, 2014 | 51 | 2014 |
| Associations between risk of mortality and atypical antipsychotic use in vascular dementia: a clinical cohort study J Sultana, CK Chang, RD Hayes, M Broadbent, R Stewart, A Corbett, ... International journal of geriatric psychiatry 29 (12), 1249-1254, 2014 | 48 | 2014 |
